Addiction drug shows promise lifting long Covid-19 brain fog, fatigue

CHICAGO - Lauren Nichols, a 34-year-old logistics expert for the US Department of Transportation in Boston, has been suffering from impaired thinking and focus, fatigue, seizures, headache and pain since her Covid-19 infection in the spring of 2020. Last June, her doctor suggested low doses of naltrexone, a generic drug typically used to treat alcohol and opioid addiction. After more...

Related Keywords

Australia ,Ann Arbor ,Michigan ,United States ,United Kingdom ,Vancouver ,British Columbia ,Canada ,Boston ,Massachusetts ,Dublin ,Ireland ,Chicago ,Illinois ,Stanford ,Leicestershire ,British ,Jaime Seltzer ,Lauren Nichols ,Sajad Zalzala ,Zach Porterfield ,Hector Bonilla ,Jack Lambert ,Sonya Marshall Gradisnik ,Department Of Transportation ,National Institutes Of Health ,University Of Alabama At Birmingham ,University College Dublin School Of Medicine ,Reuters ,National Centre For Neuroimmunology ,University Of British Columbia ,Fatigue Laboratory ,Pfizer Inc Paxlovid ,University Of Kentucky ,National Institutes ,Jarred Younger ,University College Dublin School ,National Centre ,Emerging Diseases ,Pfizer Inc ,Stanford Post Acute ,